XML 54 R35.htm IDEA: XBRL DOCUMENT v3.4.0.3
Shareholder's Equity (Details) - USD ($)
12 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Aggregate number of shares of common stock issued for conversion (in shares) 20,633,744 0  
Decrease in derivative value due to conversion $ 2,474,418 $ 0  
Common Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Aggregate number of shares of common stock issued for conversion (in shares) 20,633,744 0  
Total value of convertible debt upon conversion $ 1,728,370 $ 0  
Decrease in derivative value due to conversion $ 2,474,418 $ 0  
Common Stock [Member] | Directors [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares issued for service (in shares) 2,100 3,488  
Stock-based compensation expense $ 8,400 $ 20,001  
Option valuation using a lattice model [Abstract]      
Share-based compensation expense $ 8,400 $ 20,001  
Common Stock [Member] | Related Party [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Aggregate number of shares of common stock issued for conversion (in shares) 928,254 0  
Total value of convertible debt upon conversion $ 250,000 $ 0  
Decrease in derivative value due to conversion (432,646) 0  
Stock Options [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation expense $ 0 6,957  
Shares granted (in shares)     47,500
Stock options, exercisable period     2 years
Award vesting period     2 years
Exercise price (in dollars per share)     $ 20
Minimum price per share (in dollars per share)     $ 75
Grant date fair value of option     $ 63,711
Grant date fair value (in dollars per share)     $ 13
Option valuation using a lattice model [Abstract]      
Risk free interest rate 0.25%    
Dividend yield 0.00%    
Annual volatility 105.97%    
Exit/Attrition rates 2.00%    
Target exercise multiple 2.14%    
Share-based compensation expense $ 0 $ 6,957  
Options outstanding (in shares) 41,500    
Options exercisable (in shares) 0